The Women With Inflammatory Bowel Disease and Motherhood (WIsDoM) Study - A Study Focused on Female Fertility and IBD

Age: 18 - 45 years

Gender: Female

Healthy Subjects: Yes

Recruitment Status: Recruiting

Contact Information:
Marla Dubinsky, MD, Principal Investigator
212-824-7786
Summary:

What is the purpose of the study?

Many patients with Crohn’s disease or ulcerative colitis are women who are diagnosed with the disease during peak childbearing years. Both patients and providers frequently ask whether IBD, IBD surgery, or IBD medications affect a woman’s ability to become pregnant. Despite many advances in the field, there are several important questions about female fertility and IBD that remain unanswered and need further investigation.

The results of this study will help to answer these questions and provide essential information to IBD patients and their care teams in order to ensure that patients are supported while they try to become pregnant and during their pregnancy.

Eligibility:

 

Who can participate in the WIsDoM study?

You must be:

  • A woman with IBD
  • Aged 18 to 45 years old
  • Planning to become pregnant in the next 18 months
  • Able to consent to participation
  • Live in the United States or Canada

What does participation involve?

Once you provide consent, you will be asked to complete an initial survey, and the research team will contact you to collect information about your IBD history. You will then be asked to complete monthly surveys while trying to conceive, and then for an additional four months after becoming pregnant. You may choose to opt out of the study at any time. If you are interested in participating or learning more about the study, please visit www.redcap.link/wisdomibdstudy